Trial Profile
Immune tolerance induction in MS patients with neutralizing antibodies against interferon-beta
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2012
Price :
$35
*
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Biomarker; Therapeutic Use
- Acronyms HINABS
- 08 Jun 2011 New trial record